Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(30 sites)

United States

University of Southern California, Los Angeles, California

Yale University, New Haven, Connecticut

Baptist Medical Center - Jacksonville, Jacksonville, Florida

University of South Florida, Tampa, Florida

Northwestern University, Chicago, Illinois

Advocate Lutheran General Hospital, Park Ridge, Illinois

Indiana University, Indianapolis, Indiana

University of Kansas Medical Center, Kansas City, Kansas

University of Kentucky Research Foundation, Lexington, Kentucky

Massachusetts General Hospital, Boston, Massachusetts

Brigham and Women's Hospital, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Henry Ford Health, West Bloomfield, Michigan

Cooper Neurological Institute, Camden, New Jersey

Albany Medical Center, Albany, New York

University at Buffalo Neurosurgery, Buffalo, New York

Northwell Health, Manhasset, New York

NYU Langone Health, New York, New York

Icahn School of Medicine at Mount Sinai, New York, New York

Lenox Hill Hospital, New York, New York

University of Rochester Medical Center, Rochester, New York

Montefiore Medical Center, The Bronx, New York

Cleveland Clinic, Cleveland, Ohio

Thomas Jefferson University, Philadelphia, Pennsylvania

Rhode Island Hospital, Providence, Rhode Island

University of Texas Southwestern Medical Center, Dallas, Texas

Virginia Commonwealth University, Richmond, Virginia

Argentina

Clinica La Sagrada Familia, Buenos Aires

Canada

University of Calgary - Foothills Medical Centre, Calgary, Alberta

St. Michael's Hospital, Toronto, Ontario